CM Hospitalar S/A (BVMF: VVEO3)

Market Cap	681.58M
Revenue (ttm)	11.46B
Net Income (ttm)	182.88M
Shares Out	318.49M
EPS (ttm)	0.58
PE Ratio	3.72
Forward PE	4.82
Dividend	n/a
Ex-Dividend Date	May 2, 2024

Volume	3,707,100
Open	1.940
Previous Close	1.950
Day's Range	1.940 - 2.160
52-Week Range	1.810 - 18.770
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About CM Hospitalar S/A

CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antiandrogen, antianemic, anti-asthmatic, antibiotic, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressant, antidiabetic, antidiur...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2010
• Employees: 6,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: VVEO3

Financial Performance

In 2023, CM Hospitalar S/A's revenue was 11.08 billion, an increase of 26.72% compared to the previous year's 8.75 billion. Earnings were 359.92 million, an increase of 38.57%.